Vbi Vaccines Stock Probability of Future Stock Price Finishing Under 0.12

VBIVQ Stock   0.0005  0.0001  16.67%   
VBI Vaccines' future price is the expected price of VBI Vaccines instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of VBI Vaccines performance during a given time horizon utilizing its historical volatility. Check out VBI Vaccines Backtesting, VBI Vaccines Valuation, VBI Vaccines Correlation, VBI Vaccines Hype Analysis, VBI Vaccines Volatility, VBI Vaccines History as well as VBI Vaccines Performance.
To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide.
  
Please specify VBI Vaccines' target price for which you would like VBI Vaccines odds to be computed.

VBI Vaccines Target Price Odds to finish below 0.12

The tendency of VBI Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under  0.12  after 90 days
 0.0005 90 days 0.12 
close to 99
Based on a normal probability distribution, the odds of VBI Vaccines to stay under  0.12  after 90 days from now is close to 99 (This VBI Vaccines probability density function shows the probability of VBI Stock to fall within a particular range of prices over 90 days) . Probability of VBI Vaccines price to stay between its current price of  0.0005  and  0.12  at the end of the 90-day period is about 72.32 .
Assuming the 90 days horizon the stock has the beta coefficient of 11.54 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, VBI Vaccines will likely underperform. Additionally VBI Vaccines has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   VBI Vaccines Price Density   
       Price  

Predictive Modules for VBI Vaccines

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as VBI Vaccines. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VBI Vaccines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000530.10
Details
Intrinsic
Valuation
LowRealHigh
0.000.000530.10
Details

VBI Vaccines Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. VBI Vaccines is not an exception. The market had few large corrections towards the VBI Vaccines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold VBI Vaccines, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of VBI Vaccines within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-2.2
β
Beta against Dow Jones11.54
σ
Overall volatility
0.01
Ir
Information ratio -0.06

VBI Vaccines Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of VBI Vaccines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for VBI Vaccines can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
VBI Vaccines generated a negative expected return over the last 90 days
VBI Vaccines has high historical volatility and very poor performance
VBI Vaccines has some characteristics of a very speculative penny stock
VBI Vaccines has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 8.68 M. Net Loss for the year was (92.84 M) with profit before overhead, payroll, taxes, and interest of 0.
VBI Vaccines generates negative cash flow from operations
VBI Vaccines has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: VBI Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission

VBI Vaccines Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of VBI Stock often depends not only on the future outlook of the current and potential VBI Vaccines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VBI Vaccines' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding23.9 M

VBI Vaccines Technical Analysis

VBI Vaccines' future price can be derived by breaking down and analyzing its technical indicators over time. VBI Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of VBI Vaccines. In general, you should focus on analyzing VBI Stock price patterns and their correlations with different microeconomic environments and drivers.

VBI Vaccines Predictive Forecast Models

VBI Vaccines' time-series forecasting models is one of many VBI Vaccines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary VBI Vaccines' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about VBI Vaccines

Checking the ongoing alerts about VBI Vaccines for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for VBI Vaccines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
VBI Vaccines generated a negative expected return over the last 90 days
VBI Vaccines has high historical volatility and very poor performance
VBI Vaccines has some characteristics of a very speculative penny stock
VBI Vaccines has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 8.68 M. Net Loss for the year was (92.84 M) with profit before overhead, payroll, taxes, and interest of 0.
VBI Vaccines generates negative cash flow from operations
VBI Vaccines has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: VBI Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.